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Abstract 
This work aims to support doctor’s decision-making on predicting sepsis level and the best 
treatment for patients with microbiological problems. A set of Data Mining (DM) models was 
developed using forecasting techniques and classification models which will enable doctors’ 
decisions about the appropriate therapy to apply, as well as the most successful one. The data 
used in DM models were collected at the Intensive Care Unit (ICU) of the Centro Hospitalar do 
Porto, in Oporto, Portugal. Classification models where considered to predict sepsis level and 
therapeutic plan for patients with sepsis in a supervised learning approach. Models were 
induced making use of the following algorithms: Decision Trees, Support Vector Machines and 
Naïve Bayes classifier. Confusion Matrix, including associated metrics, and Cross-validation 
were used for the evaluation. Analysis of the total error rate, sensitivity, specificity and 
accuracy were the associated metrics used to identify the most relevant measures to predict 
sepsis level and treatment plan under study. In conclusion, it was possible to predict with great 
accuracy the sepsis level (2nd and 3rd), but not the therapeutic plan. Although the good results 
attained for sepsis (accuracy: 100%), therapeutic plan does not present the same level of 
accuracy (best: 62.8%). 
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1. Introduction 
Everyday new patients come into Intensive Care Units (ICU) in a critical health condition. 
One of the main existing problems in Intensive Medicine is related to therapeutics, more 
specifically when they should be administered to a patient. IT can have a very important role 
supporting quality and efficiency in health care, providing the right information, at the right 
time, to the right person [1, 2]. 
It is very difficult for the professionals to care of the patients and, simultaneously, document 
the operations [3, 4]. In order to overcome this limitation a project was developed called 
INTCare [5-7]. This project has the objective to make available anywhere and anytime [8, 9] 
pertinent information about the patient. During the project a lot of data (vital signs, laboratory 
results, fluid balance, ventilation and ICU scores) were converted into electronic form, enabling 
the automatic acquisition in real-time. This new reality allows for obtaining fundamental 
knowledge to the patient treatment in the right time.  
In order to reduce sepsis mortality, a set of procedures should be followed in an early stage. 
Survival medium probability decreases of 7.6% for each hour of delay in presence of an 
effective antibiotherapy. The elaboration of a therapeutic plan for sepsis may result not only in 
the reduction of mortality, but also in the substantial decrease of costs for institutions, due to 
the possible improvement in the usage of existing resources [12]. 
Consequently, the quick interpretation and precise evaluation of physiological data of 
intensive care patients’ state are going to be crucial for a more efficient and effective decision 
making by the medical staff. 
The objective of this project is to predict the patient sepsis level in real-time, determining 
whether the patient is in the second or third level of the scale [33]. In addition, making use of 
the same input variables, a set of models has been developed to predict the therapeutic.  
This work was developed in a real environment using real data obtained from the ICU of 
Centro Hospitalar do Porto, in Portugal. This paper is divided in six chapters. After this 
introduction, the background and related work are presented in the second chapter. The third 
chapter makes an overview of the data used by the Data Mining Models. Then, the fourth 
chapter introduces the Data Mining models developed and variables used. The obtained results 
are presented in the chapter five. Finally, some conclusions about the work are written and the 
future work presented. 
2. Background 
2.1 Surviving Sepsis Campaign  
A Surviving Sepsis Campaign (SSC) provides the international guidelines for the treatment of 
sepsis, severe sepsis and septic shock [13]. SSC is a program leaded by the ESICM (European 
Society of Intensive Care Medicine), ISF (International Sepsis Forum) and SCCM (Society of 
Critical Care Medicine) that aims to improve the survival diagnostic and manage patients with 
sepsis, approaching the challenges associated with it, and having as a mission [14]: 
 Increase the awareness, comprehension and knowledge; 
 Alter perceptions and behaviors; 
 Increase the rhythm of change in care standards; 
 Define the care standards for severe sepsis;  
 Reduce sepsis associated mortality by 25% in the next 5 years; 
 Work with all stakeholders for an improvement in sepsis management, through specific 
initiatives. 
a) SEPSIS 
Sepsis is classified as a severe general infection and it is hard to define, diagnose and treat [3, 
4]. It is related to a large number of clinical conditions caused by a systemic inflammatory 
response of the organism to an infection, which develops in severe sepsis, also combined with 
simple, multiple or total organ dysfunction/failure leading to death [3, 4]. It is one of the major 
causes of death in ICU. Daily is killing around 1,400 people worldwide [3, 4]. Although not 
having a clear clinical definition that can be easily adopted and communicated in its entirety, its 
absence turns sepsis diagnosis and treatment into a clinical challenge [3, 4]. Tables 1, 2 and 3 
show the variables associated to sepsis levels. These variables are essential to the development 
of classification models. 
Table 1.  Definition of Sepsis, adapted from [13, 16, 17] 
Variables Sepsis is defined as a documented or suspected infection with one or more of the 
following 
General Fever (core temperature >38.3°C) 
Hypothermia (core temperature <36°C) 
Heart rate >90 min–1 or >2 SD above the normal value for age 
Tachypnea 
Altered mental status 
Significant edema or positive fluid balance (>20 mL/kg over 24 hrs) 
Hyperglycemia (plasma glucose >120 mg/dL) in the absence of diabetes 
Inflammatory Leukocytosis (WBC count >12,000 μL–1) 
Leukopenia (WBC count <4000 μL–1) 
Normal WBC count with >10% immature forms 
Plasma C-reactive protein >2 SD above the normal value 
Plasma procalcitonin >2 SD above the normal value 
Table 2.  Definition of Severe Sepsis, adapted from [13, 16, 17] 
Variables Severe sepsis is defined as sepsis associated with organ dysfunction, hypoperfusion, 
or hypotension 
Organ  
dysfunction 
Arterial hypoxemia (PaO2/FIO2 <300) 
Acute oliguria (urine output <0.5 mL·kg-1·hr-1 or 45 mmol/L for 2 hrs) 
Creatinine > 2.0 mg/dL 
Coagulation abnormalities (INR >1.5 or aPTT >60 secs) 
Thrombocytopenia (platelet count <100,000 ìL–1) 
Hyperbilirubinemia (plasma total bilirubin > 2.0 mg/dL or 35 mmol/L) 
Tissue perfusion Hyperlactatemia (>2 mmol/L) 
Hemodynamic Arterial hypotension (SBP <90 mm Hg, MAP <65 mm Hg, or SBP decrease >40 mm Hg) 
Table 3.  Definition of Septic Shock, adapted from [13, 16, 17] 
Septic shock is defined as acute circulatory failure unexplained by other causes 
Acute circulatory failure is defined as persistent arterial hypotension (SBP <90 mmHg, 
MAP <60, or a reduction in SBP >40 mm Hg from baseline despite adequate volume resuscitation).  
 
b) Challenges and costs 
Intensive care professionals (doctors and nurses) regard sepsis as one of the most challenging 
and hard to manage conditions, because its course varies from patient to patient, and can 
develop as a result of numerous circumstances [14]. Sepsis patient management involves a 
variety of therapeutic interventions, being the effectiveness of the treatment most likely if 
serious sepsis is avoided through appropriate and preventive care. Once diagnosed, the 
objective of the therapy is to eliminate the underlying infections with antibiotics [14]. Due to 
the challenges of diagnosing and treating the complex condition in which they are, about 10% 
of sepsis patients don’t receive antibiotic treatment in adequate timing, raising mortality by 10-
15% [15]. 
Relatively to costs, sepsis imposes a significant burden on health resources, being responsible 
for 40% of ICU total expenses, which amount to up to $7.6bn USD in Europe, annually, and 
$16.7bn USD in the US, in the year 2000; being the medium cost per case of approximately 
$22.000 USD [14]. 
c) PIRO 
According to Levy et al. (2003), PIRO is a classification system proposed by John Marshall 
for stratifying the patients’ state in regard of: (P) Predisposition, (I) Insult infection, (R) 
Response and (O) Organ dysfunction [16-19]. This concept was proposed by the second 
international consensus conference about sepsis definitions in 2001, which gathered 
simultaneously the most important medical societies: SCCM - Society of Critical Care 
Medicine; ESICM - European Society of Intensive Care Medicine; ACCP - American College 
of Chest Physicians; ATS - American Thoracic Society; SIS - Surgical Infection Society [16, 
17]. The imprecision and heterogeneity of the population defined as sepsis patients led to the 
introduction of this new sepsis classification system, known as PIRO [18]. The PIRO concept 
was proposed with the objective of improving sepsis detection [19]. Besides that, organizing 
these patients in more homogenous groups can help improve clinical practice, determine 
prognostics and include these patients in clinical studies [17]. This concept allows, according to 
[20], for: a more adequate stratification of patients according to seriousness groups; outline 
clinical studies to evaluate therapeutic strategies in patients with severe sepsis, and use this tool 
to analyze outcomes. PIRO is used for the daily classification of the patients’ 
dysfunction/organic failure degree [21]. 
It is important to stress that the PIRO concept is rudimentary and appears as a research 
proposal and developing concept, needing further testing and perfecting, before being 
considered for routine application in clinical practice [16, 17]. 
Its elaboration demands extensive evaluation of sepsis’ natural history to define the variables 
that predict not only an adverse outcome, but also the response potential to the therapy [16, 
17]. 
d) Therapeutics plans 
Regarding the therapeutic plan, quick interpretation and precise evaluation of physiological 
data in ICU patient state monitoring are crucial for a more efficient and effective decision 
making by the doctors. 
2.2 Cross Industry Standard Process for Data Mining 
a) CRISP-DM Phases 
CRISP-DM (CRoss-Industry Standard Process for Data Mining) methodology was adopted 
to guide the work. The life cycle of CRISP-DM consists of six phases [32]: 
 Business understanding - The initial phase was to understand the problem, with a focus 
on project objectives and requirements from the standpoint of business, after converting 
problem objectives into goals DM; 
 Data understanding - At this phase, began the collection and subsequent use of data, 
with a view to understanding, analysis and troubleshooting of quality. Following the 
identification of relationships among data, or the detection of interesting subset thereof, 
in order to be subsequently analyzed so as to identify hidden knowledge; 
 Data preparation - This phase involves all activities necessary to build the final data 
set. These data will be used by modeling tools for subsequent analysis by DM 
algorithms. The tasks of data preparation include selection of tables, attributes and 
records, as well as transformation and cleaning of data, with a view to their subsequent 
analysis by modeling tools; 
 Modeling - At this phase, we selected several modeling techniques and their parameters 
were adjusted to optimize the results. Normally, there are several techniques for the 
same type of DM goal, and some have specific requirements on how the data is 
presented. Sometimes we need to return to the stage of data preparation; 
 Evaluation - This phase is aimed to evaluate the usefulness of the models. Within this 
work was adopted Confusion Matrix (CM): Accuracy, Sensitivity and sensibility and 
Cross-validation (CV) 10 folds. 
 Deployment - The creation of models is not the end of the project. Even if the purpose 
of the models is to increase knowledge about the data, the information obtained must be 
organized and presented so that the user can use. 
Due to the nature of the problem, this encompasses a typical DM objective of classification 
[5]. The main goal is to predict one target with two classes, i.e., classify whether a patient has 
or not sepsis. 
b) Data Mining techniques 
To overcome this problem a set of models were defined using three distinct techniques: 
Support Vector Machine (SVM), Decision Trees (DT) and Naïve Bayes (NB). The models 
were induced automatically using Oracle Data Mining [6, 7]. All the data used were obtained 
and processed automatically. 
c) Evaluation 
1) Cross-validation (CV) - In order to use all available cases and compare the 
prediction’s precision, the cross-validation (CV) was used. The data set is 
randomly divided in mutually exclusive subsets of approximately equal k sizes 
(folds). The classification model is trained and tested k times (cycles). For each 
cycle, the model is trained using k-1 folds and tested using the remaining data. 
The global estimated precision of a model is calculated by the average of the k 
individual precision measures, as shown in the following equation:  
  
 where PCV is the precision of the cross validation, k the number of used folds 
and A is the measure of precision (for example, rate of success, sensibility, 
specificity) of each fold [22]. The measure of precision used was the sensibility.  
2) Confusion Matrix (CM) - Metrics for evaluating sepsis were: the total error rate, 
acuity, sensitivity. For therapy was considered the specificity. The Confusion 
Matrix of a classifier indicates the number of correct classifications versus 
forecasts made for each class on a set of examples [23]. The CM is a technique 
commonly used in the evaluation classification problems. In the binary case, each 
example is referred to as being positive or negative [24]. Some rates can be 
derivate from CM: 
 True Positive Rate (TPR) - corresponds to the number of positive examples 
correctly classified; 
 True Negative Rate (TNR) - corresponds to the number of negative examples 
actually classified as negative; 
 False Positive Rate (FPR) - corresponds to the number of positive examples 
classified as negative; 
 False Negative Rate (FNR) - corresponds to the number of negative examples 
classified as positive; 
 From this matrix many other measures can be derived, such as [24]: 
o Total error rate = {FPR+FNR}/{n}x100(%); 
o Sensibility = {TPR}/{TPR+FNR}x100(%); 
o Specificity = {TNR}/{TNR+FPR}x100(%); 
o Accuracy of prediction = {TPR+TNR}/{n}x100(%). 
2.3 Related Work 
This work is related with the research project INTCare. The main goal of INTCare was the 
development of an Intelligent Decision Support System to predict organ failure and patient 
outcome in real-time and using online learning [8, 9]. To attain INTCare goals was necessary 
to perform a set of changes in the ICU environment [10] and in the way that the data were 
collected. 
INTCare introduced changes in the data sources type and format. Now, the laboratory results 
are collected in an open format, the patient therapeutic are accessible electronically, the vital 
signs are obtained automatically and a new Electronic Nursing Record (ENR) platform for 
collecting the nursing data in real-time called was developed. ENR is used for monitoring the 
patient data in real-time. ENR is a web-based touch screen platform available near the patient 
beds. This platform is used by nurses and by physicians to insert, validate or consulting the 
patient data. All the data are available anywhere and anytime. The new knowledge obtained by 
INTCare it is disseminated through ICU platforms / systems. The advances attained in the ICU 
technology enabled the prediction of the sepsis level and therapeutic plans. 
3. Objectives and Methodologies 
This research is focused on the prediction of sepsis and on the prediction of the therapeutic 
plan for patients with microbiological problems, based on sepsis levels. 
3.2 Objectives 
With the objective of supporting clinical decisions this work promoted the induction of DM 
models for predicting the best therapy for patients with microbiological problems, setting as a 
starting point the sepsis level. With that in mind, the following specific goals were considered: 
 Understanding to what point is it possible to predict, with a high degree of accuracy, 
the sepsis level and therapeutic plan of sepsis patients; 
 Study and define the variables that influence the therapy; 
 Develop and test a set of classification models, based in DM, that will enable the 
doctor to decide about the best therapy to apply, adequate to the patient’s problems; 
 Test the classification models with real-world data.  
 
3.1 Research Methodology 
For some time Information Systems (IS) researchers were encouraged to consider Action 
Research (AR) methodology as an adequate research approach from the various adopted 
methodologies by IS [25]. According to Avison et al. (1999), AR has ideal characteristics for 
the study of IS with a significant impact in the area [26]. In this article, this methodology was 
partially adopted because it fits the development of the project and because it uses a systematic 
cyclical method of planning: action, observation, reflection and evaluation [27, 28]. With the 
goal of developing a set of decision models that will enable the doctor to decide on the best 
therapy to apply to the patient, there was the need to explore and survey facts. In an approach 
to discover more about the nature, context, relevance and resolution of the problem, the 
implementation of a series of measures of action was started. 
Firstly, data has been studied and prepared. Then, a theoretical model has been proposed and 
elaborated, allowing for responding to he presented problem. A survey of the necessary 
indicators was also made, for the model development. After that, the variables that influence 
the therapy were studied and defined. DM models for pattern prediction were developed. 
Finally, the models were tested with real-world data, collected in real-time and treated online. 
 
4. Data Overview 
4.1 Data description 
The Data used to induce DM models were collected at the Intensive Care Unit (ICU) of 
Centro Hospitalar do Porto from 19-AUG-2011 to 04-JUL-2012, corresponding to 305 days, 
394 patients and 12 beds. Different data types were collected from: 
 12 monitors of vital signs; 
 10 mechanical ventilators; 
 Pharmaceutical data; 
 Laboratory results. 
 
The datasets provided by CHP for this project were generated from a set of real data collected 
and processed online in real-time, using the following data sources: 
 Electronic Health Record (EHR); 
 Vital Signs Monitor (VSM); 
 Laboratory (LAB); 
 Hospital Management Warehouse and Pharmacy (HMWP). 
 
Table 4 presents the associated attributes, their description and respective data source, 
referring to the initial selection. 
Table 4.  Attributes, description and data source 
Attributes  Description  Data source 
BILIRUBIN  Bilirubin LAB 
CREATININE Creatinine LAB 
HR Heart Rate VSM 
GLUCOSE Glucose LAB 
TIME Time when the clinical examination was collected LAB/VSM 
LEUKOCYTES Leukocytes LAB 
PID Patient Identifier EHR/VSM /LAB 
DR  Date recording/collection value EHR/VSM /LAB 
MAP  Mean Arterial Pressure VSM 
SBP  Systolic Blood Pressure VSM 
PLATELETS Platelets LAB 
TEMP  Temperature  VSM 
MEDICAMENT Name of medicaments HMWP 
GROUPMED_I Group of medicaments (firs level) HMWP 
GROUPMED_A Group of medicaments (secound level) HMWP 
SUBGROUPMED_I Subgroup of medicaments (third level) HMWP 
4.2 Data preparation 
In the data exploration, the statistical analysis of clinical tests and vital signs variables was 
made prior to the transformation. For a pre-validation of the values, as in table 5, the range of 
vital signs values, collected automatically, was determined by ICU doctors. 
Table 5.  Range of values of vital signs 
Attribute
  
Min Max 
MAP 0 200 
SBP  0 300 
TEMP  34 45 
HR 0 250 
 
In table 6, the minimum and maximum values of vital signs and clinical analysis are shown, 
based on sepsis limits (tables 1, 2 and 3). 
Table 6.  Maximum and minimum values of vital signs and clinical analysis defined for sepsis 
Attributes Min Max 
BILIRUBIN 0 2 
CREATININE 0 2 
GLUCOSE 0 120 
LEUKOCYTES 4000 12000 
PLATELETS 100 9999 
MAP 65 9999 
SBP  90 9999 
TEMP  36 38,3 
HR 0 90 
 
After the exploration of the data, its quality was checked, as in table 7, which shows the 
percentage of null values in all the selected attributes. 
Table 7.  Data quality 
Attributes Nulls 
BILIRUBIN 0,0368% 
CREATININE 0,0036% 
HR 0 
GLUCOSE 0,0006% 
TIME 0 
LEUKOCYTES 0,0034% 
PID 0 
DR 0 
MAP 0 
SBP 0 
PLATELETS 0,0058% 
TEMP 0 
MEDICAMENT 0 
GROUPMED_I 0 
GROUPMED_A 0 
SUBGROUPMED_I 0 
 
Table 8 presents the data obtained after the transformation. Some new attributes and records 
were added. Excepting SEPSIS_FINAL variable, the value 0 (zero) has been assigned to 
variables whose value is within the range and the value 1 for those who are out of it. 
Table 8.  Data obtained after transformation 
Attributes Data 
SEPSIS_BILIRUBIN {0;1} 
SEPSIS_CREATININE {0;1} 
SEPSIS_HR {0;1} 
SEPSIS_GLUCOSE {0;1} 
SEPSIS_LEUKOCYTES {0;1} 
SEPSIS_MAP {0;1} 
SEPSIS_SBP {0;1} 
SEPSIS_PLATELETS {0;1} 
SEPSIS_TEMP {0;1} 
SEPSIS_FINAL  {0;2;3} 
 
Regarding SEPSIS_FINAL variable, value 0 represents patients without sepsis. Value 2 
represents patients with severe sepsis and value 3 patients with septic shock. Using the value 1 
of the remaining attributes present on table 8 and according to the definitions of sepsis on the 
tables 1, 2 and 3, a procedure was developed to calculate the sepsis level for each record. The 
procedure assigns the values of 0, 2, or 3 through a simple verification as defined by sepsis in 
the referenced tables (1, 2, and 3). For SEPSIS_FINAL was not considered the patient’s 
condition with sepsis (referring to variables of table 1) as this would have to be rated with a 
value of 1. For this reason it was not possible to assign the value 1 to the variable 
SEPSIS_FINAL because, according to ICU doctors, these values are easily confused with 
patient's condition without sepsis. During the data integration process, in order to merge these 
data it was created a data view for the entire data, combining the attributes of table 4 and those 
transformed on table 8. 
Finally, it was necessary to convert continuous numeric data into a range of classes. The 
ranges were created using a 7-point scale adapted from the Clinical Global Impression - 
Severity scale (CGI-S) [3, 4]. The CGI-S allows the doctors to evaluate the disease severity [3, 
4]. In this sense, Bin Quantile Range grouping technique was used considering seven classes [3, 
4]. The classes were created using a quantile distribution of the values received by each 
variable. 
5. Data Mining Models 
Since the variables correspond to continuous and discrete values, it was opted to use the 
classification models, distinguishing the independent variables set (analysis and vital signs) 
from the dependent variable set (final sepsis and medication). The used modeling techniques, as 
referred before, are DT, SVM and NB, whose characteristics are described in table 9. 
Table 9.  Characteristics of modeling techniques 
Description Values 
Algorithm Name Support Vector Machine 
Active Learning yes 
Automatic Preparation on 
Complexity Factor 0.068966 
Kernel Function Linear 
Tolerance .001 
Algorithm Name Naive Bayes 
Automatic Preparation on 
Pairwise Threshold 0 
Singleton Threshold 0 
Algorithm Name Decision Tree 
Automatic Preparation on 
Criteria For Splits 20 
Criteria For Splits(%) .1 
Maximum tree depth 7 
Minimum Child Record Count 10 
Tree Impurity Metric Gini 
 
In order to obtain models from the data to classify sepsis level, it was essential to execute DM 
tasks to obtain new knowledge. After the data preparation and data processing tasks, a 
modeling phase has been carried out.  
Figure 1 shows the data transformations of the classification models for sepsis and the figure 
2 shows the data transformations of therapeutic plan classification models. 
 
Fig. 1. DM process to the Sepsis target 
 
 
Fig. 2. DM process to the therapeutic plan targets 
Once variables correspond to continuous and discrete values, the classification models were 
used distinguishing the independent variables (lab results and vital signs) and the dependent 
variables (the score for sepsis and medicaments group). For modeling/evaluation 70% of the 
data was used for training and the remaining 30% for testing (Holdout sampling). During the 
modeling task some parameters adjustments were made. All continuous and discrete values 
with more than 10 classes, excepting the episode number and date, were classified using the 
Quantile Bin Range. 
To generate the models, the process went through two stages: 
 The 1st stage is constituted by models M1, M2, M3 and M4, for sepsis level and 
therapeutic plan, in which attributes M1, M2 and M3 are selected manually and M4 
automatically; 
 The 2nd stage is constituted by models M5, M6, M7, M8, M9 and M19, for the 
therapeutic plan, in which all attributes are selected manually. 
Each model was developed using three different techniques (SVM, DT and NB) related to 
sepsis level condition and to the therapeutic plan. The input attributes (independent variables) 
are: 
CaseMix = {PID; Date} 
Sepsis = {Bilirubin; Creatinine; HRMax; HRMin; Glucose; Leukocytes; MAPMax; MAPMin; SBPMax; 
SBPMin; Platelets; TempMax; TempMin} 
VarSepsis = {SepsisBilirubin; SepsisCreatinine; SepsisHR; SepsisTemp; SepsisGlucose; SepsisLeukocytes; 
SepsisMAP; SepsisSBP; SepsisPlatelets} 
 
The target attribute (dependent variables) is: 
Target1 = SepsisFinal 
Target2 = Medicament / Drug 
 
Each model can be represented as follows: 
Model{M1}*{SVM;DT;NB}*{target1;target2} = {CaseMix; Sepsis} 
Model{M2}*{SVM;DT;NB}*{target1;target2} = {CaseMix; VarSepsis} 
Model{M3}*{SVM;DT;NB}*{target1;target2} = {CaseMix; Sepsis; VarSepsis} 
Model{M4}*{SVM;DT;NB}*{target1;target2} = {Automatic} 
 
For example, the independent variables related to M1 (casemix and sepsis), can be represented 
as follows: 
SEPSIS_SVM_M1_SVM = SVM * {target1} * {CaseMix; Sepsis} 
SEPSIS_DT_M1 = DT * {target1} * {CaseMix; Sepsis} 
SEPSIS_NB_M1 = NB * {target1} * {CaseMix; Sepsis} 
MED_SVM_M1 = SVM * {target2} * {CaseMix; Sepsis} 
MED_DT_M1 = DT * {target2} * {CaseMix; Sepsis} 
MED_NB_M1= NB * {target2} * {CaseMix; Sepsis} 
 
It was generated and tested a total of: 
 12 classification models (1 (target) * 4 (scenarios) * 3 (DM techniques)) to predict 
sepsis level; 
 64 classification models (3 (target) * 6 (scenarios) * 3 (DM techniques)) to predict 
therapeutic plan. 
In order to use all available cases and compare the prediction’s precision, the CV method was 
used to estimate the synthesis capacity of the classification models. As the ODM implements 
cross validation in its techniques [29], it was possible to test the model’s precision over the 
used data. Once the results can depend on the random division of the mutually exclusive sub-
sets, 10 executions were applied to each 10-fold sub-set, in a total of 10*10 = 100 results for 
each test configuration. For evaluation, in order to compare the sepsis level classification 
models, a ROC curve analysis [30] was made. The ROC (Receiver Operating Characteristic) 
curves are frequently used in the medical field to evaluate decision support computational 
models, diagnosis and prognosis [31]. 
6. Results 
In order to assess the results attained by the models developed for sepsis a set of measures 
were applied. Figure 3 shows, ordered by average accuracy, the values of accuracy for each 
classification model and the technique used. All of the M4 models for each technique use 
variables defined automatically by the engine. The other models were characterized using a 
manual selection of the variables. 
 Fig. 3. All the models developed for sepsis 
 
From the twelve scenarios considered relatively to the sepsis level, the top three non-
automatic models (one of each technique) were selected for analysis: SEPSIS_SVM_M3, 
SEPSIS_DT_M3 SEPSIS_NB_M1 (Figure 3). Tables 10, 11 and 12 show the best prediction 
results for each set of variables selected, considering the technique and the corresponding 
scenario and the values for total error, sensitivity, specificity and accuracy. 
Table 10. Confusion matrix model SEPSIS_SVM_M3 
Model SEPSIS_SVM_M3 Severe sepsis Septic shock Total Corrects 
Severe sepsis 334 0 334 100% 
Septic shock 0 1.415 1.415 100% 
Total 334 1.415 1.749   
Corrects 100% 100%     
     
Total error Sensitivity Specificity Accuracy 
0% 100% 100% 100% 
Table 11. Confusion matrix model SEPSIS_DT_M3 
Model SEPSIS_DT_M3 Severe sepsis Septic shock Total Corrects 
Severe sepsis 334 0 334 100% 
Septic shock 0 1.415 1.415 100% 
Total 334 1.415 1.749   
Corrects 100% 100%     
     
Total error Sensitivity Specificity Accuracy 
0% 100% 100% 100% 
Table 12. Confusion matrix model SEPSIS_NB_M1 
Model SEPSIS_NB_M1 Severe sepsis Septic shock Total Corrects 
Severe sepsis 109 0 109 100% 
Septic shock 1 436 437 99,77% 
Total 110 436 546   
Corrects 99,09% 100%     
     
Total error Sensitivity Specificity Accuracy 
0,18% 100% 99,09% 99,82% 
 
Confusion matrices permit conclude that the best predictions for sepsis level are provided by 
SEPSIS_SVM_M3, SEPSIS_DT_M3 and SEPSIS_NB_M1 as presented on tables 10, 11 
and 12 respectively. 
From the results obtained for sepsis levels the Figure 4 shows the ROC curve obtained from 
SEPSIS_DT_M3 and SEPSIS_SVM_M3 models, considered the best models in terms of 
accuracy (100%). In figure 5 it is represented the decision tree obtained from the 
SEPSIS_DT_M3 model.  
       
Fig. 4. All the models developed for sepsis   Fig. 5. Decision tree for SEPSIS_DT_M3 
 
In conclusion, it is possible to predict sepsis level with a great accuracy. Regarding sepsis 
level, the accuracy, sensitivity and specificity results were 100% for SEPSIS_DT_M3 and 
SEPSIS_SVM_M3 models. SEPSIS_NB_M1 model presented 100% for sensitivity, 99.99% 
for specificity and 99.82% for accuracy. 
In terms of sepsis’ therapeutic plan, an analysis looking for the best model per target was 
carried out. Table 13 summarizes the results obtained, considering only the top eight models 
from sixty four scenarios tested. In the superior division are presented four models which were 
developed through manual selection of attributes. In the inferior division are presented four 
models based on automatic selection of attributes.  
Table 13.  Best model obtained for target related to therapy 
Targets  Classes Models Acuity 
GROUPMED_I (1st level) 13 MED_DT_M8 48,90% 
GROUPMED_A (2nd level) 49 MED_NB_M8 45,30% 
SUBGROUPMED_I (3th level) 37 MED_DT_M6 45,19% 
MEDICAMENT 75 MED_DT_M8 34,11% 
GROUPMED_I (1st level) 13 MED_DT_M4 62,84% 
GROUPMED_A (2nd level) 49 MED_SVM_M4 44,00% 
SUBGROUPMED_I (3th level) 37 MED_SVM_M4 55,23% 
MEDICAMENT 75 MED_SVM_M4 36,24% 
7. Discussion 
 The obtained results are the culmination of an entire process of acquisition and 
transformation of data, as well as model induction. In the data analysis, a total of 7 202 272 
records were treated, from which there were several with null or out of range values. After the 
data selection, a treatment and transformation process was executed. A final set of data 
containing a total of 193 122 records was obtained to feed DM models. In regard of the sepsis 
levels prediction, very good results were attained with the classification models, which 
represent 100% of accuracy. The same cannot be said regarding the therapeutic plan 
prediction. The goal was achieved only partially. Results demonstrate that the correlation 
between sepsis level and therapeutic plan is weak. All data used in this work is from real world, 
acquired in real-time. This means that the resulted models can be integrated in a decision 
support system to aid doctors in their decision making processes.  
8. Conclusions 
Results attained in this work prove that it is possible to predict the Sepsis level in real-time 
using Data Mining. 
This paper presented the classification models induced by using data collected in real time 
from the ICU of CHP, Porto, Portugal. It was considered a large initial data set which resulted, 
after processing, in a total of 193 112 records, relating to 394 episodes that occurred during 
305 days. 
DM techniques were used to extract knowledge. SVM, DTs and NB algorithms were applied 
in order to search patterns (SEPSIS Levels) and subsequent discovery of useful information. 
Results obtained have high acuity. In regard to therapeutics, the acuity results weren’t 
satisfactory but, in spite of that, good levels of assertiveness were verified in some 
drugs/medication groups. 
The assessment of sepsis level is a crucial task for intensive care environments. So as soon as 
the risk is identified, more quickly it is applied the best and more accurate treatment. The 
development of classification models for sepsis is associated to some benefits, such as mortality 
decreasing and substantial costs reduction for institutions. Besides diagnosing the correct sepsis 
level, predicting the correct treatment also avoids medication testing costs. 
The development of classification models for sepsis can be seen as a major contribute for 
developing a decision support system. Some experiences were done in order to understand some 
therapeutics tendencies, however the results weren’t satisfactory. The results suggest that 
sepsis level and patient therapeutic plan aren’t related. 
9. Future Work 
Further work includes: 
 To determine new variables that may be used to predict therapeutic; 
 To build new models about therapeutic due to the great correlation between the input 
variables (sepsis level) and target (therapeutic); 
 To implement a decision support system based on the models of sepsis developed in 
this project. 
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